The Different Immunoregulatory Functions on Dendritic Cells between Mesenchymal Stem Cells Derived from Bone Marrow of Patients with Low-Risk or High-Risk Myelodysplastic Syndromes

Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy

(2011) Shikhar Aggarwal et al.   BRITISH JOURNAL OF HAEMATOLOGY

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients

(2010) A C Chan et al.   LEUKEMIA

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2

(2009) G. M. Spaggiari et al.   BLOOD

IL-17-producing CD4+T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome

(2009) Shahram Y. Kordasti et al.   BRITISH JOURNAL OF HAEMATOLOGY

Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes

(2009) Fiorella Alfinito et al.   BRITISH JOURNAL OF HAEMATOLOGY

Immunosuppressive Properties of Mesenchymal Stem Cells Derived from Bone Marrow of Patients with Chronic Myeloid Leukemia

(2008) Zhi-Gang Zhao et al.   IMMUNOLOGICAL INVESTIGATIONS